Marek Sanak Selected Research

Prostaglandin D2

1/2022	Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.
1/2021	Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study.
1/2021	Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD.
1/2020	Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
1/2019	Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
8/2015	9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
4/2013	Exhaled eicosanoid profiles in children with atopic asthma and healthy controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marek Sanak Research Topics

Disease

52	Asthma (Bronchial Asthma) 01/2022 - 01/2003
24	Hypersensitivity (Allergy) 01/2022 - 04/2004
15	Inflammation (Inflammations) 03/2022 - 04/2013
13	Aspirin-Induced Asthma 01/2020 - 05/2003
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2022 - 03/2009
8	Eosinophilia 01/2021 - 01/2011
8	Urticaria (Hives) 01/2019 - 04/2004
7	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 02/2012
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2005
6	Rhinosinusitis 01/2019 - 03/2006
5	COVID-19 07/2022 - 01/2020
5	Angioedema 01/2019 - 04/2004
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 06/2017
4	Infections 12/2021 - 08/2014
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 03/2010
4	Myocardial Infarction 11/2020 - 01/2016
3	Choroidal Neovascularization 03/2021 - 02/2012
3	Metaplasia 01/2021 - 10/2013
3	Hemorrhage 11/2019 - 09/2010
3	Nasal Polyps (Nasal Polyp) 01/2019 - 01/2016
3	Anaphylaxis (Anaphylactic Shock) 01/2019 - 05/2013
3	Atherosclerosis 01/2018 - 03/2010
3	Hearing Loss (Hearing Impairment) 10/2015 - 04/2000
3	Lung Diseases (Lung Disease) 01/2012 - 01/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2013
2	Virus Diseases (Viral Diseases) 01/2022 - 03/2006
2	Central Serous Chorioretinopathy 10/2021 - 03/2021
2	Necrosis 03/2021 - 01/2018
2	Hypertension (High Blood Pressure) 03/2021 - 02/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2005
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2011
2	Thrombosis (Thrombus) 11/2020 - 02/2014
2	Disease Progression 01/2017 - 01/2009
2	Obesity 11/2016 - 01/2013
2	Aneurysm (Aneurysms) 10/2016 - 01/2016
2	Acute Coronary Syndrome 02/2016 - 11/2008
2	Hypercholesterolemia 02/2014 - 01/2005

Drug/Important Bio-Agent (IBA)

29	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2003
18	EicosanoidsIBA 01/2022 - 01/2004
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2013
11	ProstaglandinsIBA 01/2021 - 05/2003
10	LeukotrienesIBA 01/2022 - 10/2010
10	Dinoprostone (PGE2)FDA Link 01/2021 - 05/2003
8	MicroRNAs (MicroRNA)IBA 03/2022 - 10/2015
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 04/2004
8	Immunoglobulin E (IgE)IBA 01/2022 - 11/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 02/2012
7	AntibodiesIBA 03/2022 - 02/2012
7	Prostaglandin D2IBA 01/2022 - 04/2013
6	Leukotriene E4IBA 01/2021 - 01/2012
6	Pharmaceutical PreparationsIBA 10/2020 - 05/2013
6	SteroidsIBA 01/2020 - 03/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
5	CytokinesIBA 05/2022 - 01/2012
5	LipidsIBA 01/2021 - 01/2013
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 03/2006
4	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2012
4	Arachidonic Acid (Vitamin F)IBA 01/2019 - 03/2006
4	Retinaldehyde (Retinal)IBA 01/2016 - 02/2012
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2006 - 05/2003
3	Complement System Proteins (Complement)IBA 05/2022 - 01/2015
3	Biological ProductsIBA 01/2022 - 09/2006
3	Interleukin-8 (Interleukin 8)IBA 03/2021 - 01/2019
3	InterferonsIBA 03/2021 - 09/2012
3	Interleukin-4 (Interleukin 4)IBA 03/2021 - 10/2012
3	ThromboxanesIBA 01/2021 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2016
3	AcidsIBA 01/2021 - 10/2010
3	ChemokinesIBA 01/2019 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2014
3	Bevacizumab (Avastin)FDA Link 11/2016 - 02/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 03/2021 - 11/2019
2	InterleukinsIBA 03/2021 - 09/2012
2	Interleukin-10 (Interleukin 10)IBA 03/2021 - 10/2012
2	Interleukin-5 (Interleukin 5)IBA 03/2021 - 10/2012
2	Particulate MatterIBA 01/2021 - 07/2014
2	IsoprostanesIBA 01/2021 - 09/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2012
2	5-oxo-eicosatetraenoic acidIBA 01/2021 - 01/2020
2	11-dehydro-thromboxane B2IBA 01/2021 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020 - 01/2019
2	Cocaine (Cocaine HCl)IBA 07/2020 - 01/2019
2	Leukotriene B4IBA 01/2020 - 01/2019
2	Interleukin-13IBA 11/2019 - 10/2013
2	ProteomeIBA 01/2019 - 01/2018
2	Leukotriene C4IBA 01/2019 - 04/2013
2	RNA (Ribonucleic Acid)IBA 11/2018 - 01/2003
2	EnzymesIBA 01/2018 - 01/2004
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 01/2005
2	Immunoglobulin G (IgG)IBA 12/2016 - 02/2014
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2016 - 09/2015
2	GlucocorticoidsIBA 10/2015 - 06/2010
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 10/2013 - 10/2010
2	Hydroxyeicosatetraenoic Acids (HETE)IBA 10/2013 - 10/2010
2	LDL Receptors (LDL Receptor)IBA 01/2013 - 05/2012

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 09/2010
2	Secondary Prevention 01/2018 - 01/2007